Post-Treatment Follow-up Study for Liver Disease Subjects With or Without Cirrhosis After Receiving Emricasan or Placebo

Clinical trial NCT03479125 · TERMINATED

Trial details

NCT number: NCT03479125
Sponsor: Conatus Pharmaceuticals Inc.
Status: TERMINATED
Study type: OBSERVATIONAL

Liver Diseases Liver Fibrosis Liver Cirrhosis NASH Fibrosis Decompensated Non-Alcoholic Steatohepatitis Cirrhosis Orthotopic Liver Transplantation

Start date: 2018-02-27
Primary completion: 2019-08-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.